Assignee
ATHENA NEUROSCIENCES INC
US·47 granted patents·2,748 citations·filing 1991–2006
Top patents by PatentIndex Score
47 records- 0198US5721130AAntibodies and fragments thereof which bind the carboxyl-terminus of an amino-terminal fragment of βAPPATHENA NEUROSCIENCES INC·Filed 1995·Granted Feb 24, 1998·244 cites·14 claims
- 0298US5720936ATransgenic mouse assay for compounds affecting amyloid protein processingATHENA NEUROSCIENCES INC·Filed 1994·Granted Feb 24, 1998·174 cites·6 claims
- 0398US5612486ATransgenic animals harboring APP allele having swedish mutationATHENA NEUROSCIENCES INC·Filed 1993·Granted Mar 18, 1997·324 cites·4 claims
- 0498US5441870AMethods for monitoring cellular processing of β-amyloid precursor proteinATHENA NEUROSCIENCES INC·Filed 1992·Granted Aug 15, 1995·316 cites·26 claims
- 0597US5840299AHumanized antibodies against leukocyte adhesion molecule VLA-4ATHENA NEUROSCIENCES INC·Filed 1995·Granted Nov 24, 1998·323 cites·29 claims
- 0696US5605811AMethods and compositions for monitoring cellular processing of beta-amyloid precursor proteinATHENA NEUROSCIENCES INC·Filed 1995·Granted Feb 25, 1997·180 cites·7 claims
- 0796US5604102AMethods of screening for β-amyloid peptide production inhibitorsATHENA NEUROSCIENCES INC·Filed 1993·Granted Feb 18, 1997·165 cites·19 claims
- 0894US5837672AMethods and compositions for the detection of soluble β-amyloid peptideATHENA NEUROSCIENCES INC·Filed 1995·Granted Nov 17, 1998·185 cites·14 claims
- 0994US5744346Aβ-secretaseATHENA NEUROSCIENCES INC·Filed 1995·Granted Apr 28, 1998·208 cites·6 claims
- 1091US6653303B1Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compoundsATHENA NEUROSCIENCES INC·Filed 2003·Granted Nov 25, 2003·16 cites·30 claims
- 1189US6544978B2Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compoundsATHENA NEUROSCIENCES INC·Filed 2001·Granted Apr 8, 2003·16 cites·32 claims
- 1288US5707821AIdentification of phospholipase A2 inhibitors in Aβ peptide-mediated neurodegenerative diseaseATHENA NEUROSCIENCES INC·Filed 1995·Granted Jan 13, 1998·40 cites·7 claims
- 1387US6541466B2Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compoundsATHENA NEUROSCIENCES INC·Filed 2001·Granted Apr 1, 2003·10 cites·32 claims
- 1484US6492421B1Substituted phenylalanine type compounds which inhibit leukocyte adhesion mediated by VLA-4ATHENA NEUROSCIENCES INC·Filed 1998·Granted Dec 10, 2002·52 cites·35 claims
- 1582US5538845ABeta-amyloid peptide production inhibitors and methods for their identificationATHENA NEUROSCIENCES INC·Filed 1992·Granted Jul 23, 1996·74 cites·38 claims
- 1682US5424205AAmyloidin protease and uses thereofATHENA NEUROSCIENCES INC·Filed 1993·Granted Jun 13, 1995·71 cites·11 claims
- 1780US6849650B2Heterocyclic compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compoundsATHENA NEUROSCIENCES INC·Filed 2002·Granted Feb 1, 2005·9 cites·15 claims
- 1877US5292652AAmyloidin protease and uses thereofATHENA NEUROSCIENCES INC·Filed 1991·Granted Mar 8, 1994·36 cites·15 claims
- 1976US6291453B14-amino-phenylalanine type compounds which inhibit leukocyte adhesion mediated by VLA-4ATHENA NEUROSCIENCES INC·Filed 1998·Granted Sep 18, 2001·20 cites·32 claims
- 2076US6096782AN-(aryl/heteroaryl) amino acid derivatives pharmaceutical compositions comprising same and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compoundsATHENA NEUROSCIENCES INC·Filed 1997·Granted Aug 1, 2000·18 cites·27 claims
- 2175US6559141B2Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compoundsATHENA NEUROSCIENCES INC·Filed 2001·Granted May 6, 2003·2 cites·32 claims
- 2274US6506782B1Heterocyclic compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compoundsATHENA NEUROSCIENCES INC·Filed 1998·Granted Jan 14, 2003·38 cites·53 claims
- 2372US5866318AInhibition of phospholipase A2 to reduce neuronal cell deathATHENA NEUROSCIENCES INC·Filed 1995·Granted Feb 2, 1999·16 cites·12 claims
- 2472US5858982ACathepsin and methods and compositions for inhibition thereofATHENA NEUROSCIENCES INC·Filed 1997·Granted Jan 12, 1999·20 cites·13 claims
- 2571US6579867B2Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compoundsATHENA NEUROSCIENCES INC·Filed 2001·Granted Jun 17, 2003·2 cites·14 claims
- 2669US5849711ACathepsin and methods and compositions for inhibition thereofATHENA NEUROSCIENCES INC·Filed 1995·Granted Dec 15, 1998·17 cites·8 claims
- 2768US6423688B1Dipeptide and related compounds which inhibit leukocyte adhesion mediated by VLA-4ATHENA NEUROSCIENCES INC·Filed 1998·Granted Jul 23, 2002·16 cites·8 claims
- 2866US6632811B2Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compoundsATHENA NEUROSCIENCES INC·Filed 2001·Granted Oct 14, 2003·1 cites·13 claims
- 2965US6667305B1Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compoundsATHENA NEUROSCIENCES INC·Filed 2003·Granted Dec 23, 2003·1 cites·13 claims
- 3063US7390801B2Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compoundsATHENA NEUROSCIENCES INC·Filed 2006·Granted Jun 24, 2008·0 cites·10 claims
- 3163US6559127B1Compounds which inhibit leukocyte adhesion mediated by VLA-4ATHENA NEUROSCIENCES INC·Filed 1998·Granted May 6, 2003·12 cites·15 claims
- 3262US6683075B1Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by useATHENA NEUROSCIENCES INC·Filed 2003·Granted Jan 27, 2004·2 cites·29 claims
- 3361US6117901AN-(aryl/heteroarylacetyl) amino acid esters, pharmaceutical compositions comprising same, and methods for useATHENA NEUROSCIENCES INC·Filed 1997·Granted Sep 12, 2000·18 cites·23 claims
- 3460US5965614AN-(aryl/heteroaryl) amino acid esters, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compoundsATHENA NEUROSCIENCES INC·Filed 1997·Granted Oct 12, 1999·6 cites·12 claims
- 3558US6767918B2N-(aryl/heteroarylacetyl) amino acid esters, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compoundsATHENA NEUROSCIENCES INC·Filed 2002·Granted Jul 27, 2004·0 cites·29 claims
- 3657US6838455B2Deoxyamino acid compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compoundsATHENA NEUROSCIENCES INC·Filed 2002·Granted Jan 4, 2005·0 cites·42 claims
- 3757US6635632B1Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compoundsATHENA NEUROSCIENCES INC·Filed 1997·Granted Oct 21, 2003·6 cites·60 claims
- 3856US6642261B2N-(aryl/heteroarylacety) amino acid esters, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compoundsATHENA NEUROSCIENCES INC·Filed 2001·Granted Nov 4, 2003·0 cites·17 claims
- 3956US6362341B1Benzyl compounds which inhibit leukocyte adhesion mediated by VLA-4ATHENA NEUROSCIENCES INC·Filed 1998·Granted Mar 26, 2002·7 cites·18 claims
- 4055US5604131AcDNA-genomic DNA hybrid sequence encoding APP770 containing a genomic DNA insert of the KI and OX-2 regionsATHENA NEUROSCIENCES INC·Filed 1993·Granted Feb 18, 1997·15 cites·3 claims
- 4149US5792799AParenteral delivery of MAO A inhibitorsATHENA NEUROSCIENCES INC·Filed 1996·Granted Aug 11, 1998·21 cites·13 claims
- 4246US5462740ARectally-administered, epileptic-seizure-inhibiting compositionATHENA NEUROSCIENCES INC·Filed 1993·Granted Oct 31, 1995·56 cites·8 claims
- 4345US6399628B1N-(aryl/heteroaryl) amino acid esters, pharmaceutical compositions comprising same, and methods for inhibiting alpha- amyloid peptide release and/or its synthesis by use of such compoundsATHENA NEUROSCIENCES INC·Filed 1999·Granted Jun 4, 2002·2 cites·20 claims
- 4436US5422244ADetection of brain α1-antichymotrypsinATHENA NEUROSCIENCES INC·Filed 1992·Granted Jun 6, 1995·8 cites·26 claims
- 4534US6495693B2N-(aryl/heteroaryl) amino acid derivatives, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compoundsATHENA NEUROSCIENCES INC·Filed 1999·Granted Dec 17, 2002·0 cites·72 claims
- 4634US6333351B1N-(aryl/heteroarylacetyl) amino acid esters, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compoundsATHENA NEUROSCIENCES INC·Filed 1999·Granted Dec 25, 2001·1 cites·20 claims
- 4732US6313152B1N(aryl/heteroarylacetyl) amino acid esters, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compoundsATHENA NEUROSCIENCES INC·Filed 1999·Granted Nov 6, 2001·0 cites·12 claims
Join the waitlist — get patent alerts
Get an alert when ATHENA NEUROSCIENCES INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →